Oncological outcomes of conversion therapy in gastric cancer patients with peritoneal metastasis: a large-scale retrospective cohort study
Zhongyin Yang(Shanghai Jiao Tong University), Zhenggang Zhu(Wuhan Center for Disease Control and Prevention), Chao Yan(Shanghai Jiao Tong University), Jun Zhang(Qingdao University), Xuexin Yao(Shanghai Jiao Tong University), Yanan Zheng(Zhejiang Chinese Medical University), Sheng Lu(Shanghai Jiao Tong University), Min Yan(Zhengzhou University), Hong Yuan(People's Hospital of Xinjiang Uygur Autonomous Region), Wentao Liu(Shanghai Jiao Tong University), Min Shi(Hebei Medical University), Zhenqiang Wang(Qilu University of Technology), Changyu He(Shanghai Jiao Tong University), Zhentian Ni(Ruijin Hospital), Chen Li(Shanghai Jiao Tong University), Zhenglun Zhu(Brigham and Women's Hospital)
Cited by 16
Related Papers
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023
|癌症：英文版|2023|412
IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway
|Oncotarget|2017|400
miR-126 functions as a tumour suppressor in human gastric cancer
|Cancer Letters|2010|298